EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gene Expression of CSF3R/CD114 Is Associated with Poorer Patient Survival in Glioma

Samir Ale Bark, Matheus Dalmolin, Osvaldo Malafaia, Rafael Roesler iD, Marcelo A C Fernandes, Gustavo R Isolan

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25053020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Samir Ale Bark und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Principles of Surgery, Mackenzie Evangelical University, Curitiba 80730-000, PR, Brazil. Hauptthemen laut MEDLINE: Glioma, Glioblastoma, Astrocytoma, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, The Center for Advanced Neurology and Neurosurgery (CEANNE), Mackenzie Evangelical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gliomas comprise most cases of central nervous system (CNS) tumors. Gliomas afflict both adults and children, and glioblastoma (GBM) in adults represents the clinically most important type of malignant brain cancer, with a very poor prognosis. The cell surface glycoprotein CD114, which is encoded by the CSF3R gene, acts as the receptor for the granulocyte colony stimulating factor (GCSF), and is thus also called GCSFR or CSFR. CD114 is a marker of cancer stem cells (CSCs), and its expression has been reported in several cancer types. In addition, CD114 may represent one among various cases where brain tumors hijack molecular mechanisms involved in neuronal survival and synaptic plasticity. Here, we describe CSF3R mRNA expression in human gliomas and their association with patient prognosis as assessed by overall survival (OS). We found that the levels of CSF3R/CD114 transcripts are higher in a few different types of gliomas, namely astrocytoma, pilocytic astrocytoma, and GBM, in comparison to non-tumoral neural tissue. We also observed that higher expression of CSF3R/CD114 in gliomas is associated with poorer outcome as measured by a shorter OS. Our findings provide early evidence suggesting that CSF3R/CD114 shows a potential role as a prognosis marker of OS in patients with GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaGlioblastomaAstrocytomaBrain NeoplasmsCentral Nervous System NeoplasmsAdultChildHumansSignal TransductionGene ExpressionReceptors, Colony-Stimulating Factor

Stichwörter der Autor:innen

CD114CSF3Rbrain tumorglioblastomagliomagranulocyte colony stimulating factor

Substanzen

CSF3R protein, humanReceptors, Colony-Stimulating Factor

Autor:innen und Institutionen

  • Graduate Program in Principles of Surgery, Mackenzie Evangelical University, Curitiba 80730-000, PR, Brazil.
  • The Center for Advanced Neurology and Neurosurgery (CEANNE), Porto Alegre 90560-010, RS, Brazil.
  • InovAI Lab, nPITI/IMD, Federal University of Rio Grande do Norte, Natal 59078-970, RN, Brazil.
  • Bioinformatics Multidisciplinary Environment (BioME), Federal University of Rio Grande do Norte, Natal 59078-970, RN, Brazil.
  • Department of Pharmacology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre 90035-003, RS, Brazil.
  • Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, RS, Brazil.

ORCID-Profile: Rafael Roesler

Förderung

  • National Council for Scientific and Technological Development
  • The Center for Advanced Neurology and Neurosurgery (CEANNE)
  • Mackenzie Evangelical University
  • Children’s Cancer Institute (ICI)

Zitieren

APA

Bark, S. A., Dalmolin, M., Malafaia, O., Roesler, R., Fernandes, M. A. C., & Isolan, G. R. (2024). Gene Expression of CSF3R/CD114 Is Associated with Poorer Patient Survival in Glioma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25053020

Vancouver

Bark SA, Dalmolin M, Malafaia O, Roesler R, Fernandes MAC, Isolan GR. Gene Expression of CSF3R/CD114 Is Associated with Poorer Patient Survival in Glioma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25053020

BibTeX
@article{Bark2024,
  author = {Bark, Samir Ale and Dalmolin, Matheus and Malafaia, Osvaldo and Roesler, Rafael and Fernandes, Marcelo A C and Isolan, Gustavo R},
  title = {Gene Expression of CSF3R/CD114 Is Associated with Poorer Patient Survival in Glioma},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25053020}
}
Kostenlos starten →